2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

Cited by (1,013)

Items 501–600 of 1,013

1. Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study
   María Lorenza Muiesan, Massimo Salvetti, Agostino Virdis, Stefano Masi, Edoardo Casiglia, Valérie Tikhonoff, Carlo Maria Barbagallo, Michele Bombelli, Arrigo F.G. Cicero, Massimo Círillo et al. · 2020 · Journal of Hypertension
2. Natriuretic Equation to Predict Loop Diuretic Response in Patients With Heart Failure
   Veena S. Rao, Juan Betuel Ivey-Miranda, Zachary L. Cox, Ralph J. Riello, Matthew Dallas Griffin, James H. Fleming, Richard J. Soucier, Prasama Sangkachand, Margaret O’Brien, Francine Lorusso et al. · 2021 · Journal of the American College of Cardiology
3. Long-Term Follow-Up of DANISH (The Danish Study to Assess the Efficacy of ICDs in Patients With Nonischemic Systolic Heart Failure on Mortality)
   Adelina Yafasova, Jawad H. Butt, Marie B. Elming, Jens C. Nielsen, Jens Haarbo, Lars Videbæk, Line L. Olesen, Flemming Hald Steffensen, Niels E. Bruun, Hans Eiskjær et al. · 2021 · Circulation
4. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome
   Dimitrios T. Farmakis, Panagiotis Simitsis, Vasiliki Bistola, Filippos K. Triposkiadis, Ignatios Ikonomidis, Spyridon Katsanos, George Bakosis, Erifili E. Hatziagelaki, John P Lekakis, Alexandre Mebazaa et al. · 2016 · Clinical Research in Cardiology
5. Associations between Skeletal Muscle and Myocardium in Aging: A Syndrome of “Cardio‐Sarcopenia”?
   Bryan M.H. Keng, Fei Gao, Louis LY Teo, Wee Shiong Lim, Ru‐San Tan, Wen Ruan, See Hooi Ewe, Woon‐Puay Koh, Angela Su-Mei Koh · 2019 · Journal of the American Geriatrics Society
6. The Difference in Referencing in Web of Science, Scopus, and Google Scholar
   Markus S. Anker, Sara Hadzibegovic, Alessia Lena, Wilhelm Haverkamp · 2019 · ESC Heart Failure
7. Energy metabolism disorders and potential therapeutic drugs in heart failure
   Yanan He, Wei Huang, Chen Zhang, Lumeng Chen, Runchun Xu, Nan Li, Fang Wang, Li Han, Ming Yang, Dingkun Zhang · 2020 · Acta Pharmaceutica Sinica B
8. One‐year results of the first‐in‐man study investigating the Atrial Flow Regulator for left atrial shunting in symptomatic heart failure patients: the PRELIEVE study
   Christina Paitazoglou, Martin W. Bergmann, Рамазан Оздемир, Roman Pfister, Jozef Bartúnek, Teoman Kılıç, Alexander Lauten, Alexander Schmeißer, Mehdi Zoghi, Stefan D. Anker et al. · 2021 · European Journal of Heart Failure
9. Past, Present, and Future of Blood Biomarkers for the Diagnosis of Acute Myocardial Infarction—Promises and Challenges
   Ioan Ţilea, Andreea Varga, Răzvan Constantin Şerban · 2021 · Diagnostics
10. Chagas heart disease: An overview of diagnosis, manifestations, treatment, and care
    Roberto Magalhães Saraiva, Mauro Felippe Felix Mediano, Fernanda Sns Mendes, Gilberto Marcelo Sperandio da Silva, Henrique Horta Veloso, Luiz Henrique Conde Sangenis, Paula Simplício da Silva, Flavia Mazzoli‐Rocha, Andréa Silvestre de Sousa, Marcelo Teixeira de Holanda et al. · 2021 · World Journal of Cardiology
11. Impact of Haemoconcentration During Acute Heart Failure Therapy on Mortality and its Relationship with Worsening Renal Function
    Tobias Breidthardt, Zoraida Moreno Weidmann, Raphael Twerenbold, Claudine Gantenbein, Fabio Stallone, Katharina Rentsch, María Rubini Giménez, Nikola Kozhuharov, Zaid Sabti, Dominik Breitenbücher et al. · 2016 · European Journal of Heart Failure
12. Impact of Systolic Blood Pressure on the Safety and Tolerability of Initiating and Up-Titrating Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction: Insights from the TITRATION Study
    Michele Senni, John J.V. McMurray, Rolf Wachter, Hugh Farrell McIntyre, Inder S. Anand, Vincenzo Duino, Arnab Sarkar, Victor Chengwei Shi, Alan Charney · 2017 · European Journal of Heart Failure
13. The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction
    Christina Paitazoglou, Рамазан Оздемир, Roman Pfister, Martin W. Bergmann, Jozef Bartúnek, Teoman Kılıç, Alexander Lauten, Alexander Schmeißer, Mehdi Zoghi, Stefan D. Anker et al. · 2019 · EuroIntervention
14. Urinary Levels of Novel Kidney Biomarkers and Risk of True Worsening Renal Function and Mortality in Patients with Acute Heart Failure
    Mateusz Sokolski, Robert Zymliński, Jan Biegus, Paweł Siwołowski, Sylwia Nawrocka‐Millward, John Todd, Malli Rama Yerramilli, Joel Estis, Ewa Anita Jankowska, Waldemar Banasiak et al. · 2017 · European Journal of Heart Failure
15. Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor
    Surya P. Ayalasomayajula, Thomas Langenickel, Parasar Pal, Sreedevi Boggarapu, Gangadhar Sunkara · 2017 · Clinical Pharmacokinetics
16. Iron Deficiency and Red Cell Indices in Patients with Heart Failure
    Michał Tkaczyszyn, Josep Comin Colet, Adriaan A. Voors, Dirk Jan van Veldhuisen, Cristina Enjuanes, Pedro Moliner, Piotr Rozentryt, Lech Poloński, Waldemar Banasiak, Piotr P. Ponikowski et al. · 2017 · European Journal of Heart Failure
17. A Hospital-Community-Family–Based Telehealth Program for Patients With Chronic Heart Failure: Single-Arm, Prospective Feasibility Study
    Xiaorong Guo, Xiang Q. Gu, Jiang Jiang, Hongxiao Li, Ruo-Yu Duan, Yi Zhang, Lei Sun, Zhengyu Bao, Jianhua Shen, Fukun Chen · 2019 · JMIR mhealth and uhealth
18. Safety, pharmacodynamic, and pharmacokinetic characterization of vericiguat: results from six phase I studies in healthy subjects
    Michael Böettcher, Dirk Thomas, Wolfgang Mueck, Stephanie Loewen, Erich R. Arens, Kenichi Yoshikawa, Corina Becker · 2020 · European Journal of Clinical Pharmacology
19. SIRT3 as a potential therapeutic target for heart failure
    Jie Chen, Shiqi Chen, Bingxia Zhang, Junwei Liu · 2021 · Pharmacological Research
20. Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure
    Michele Emdin, Gianluca Mirizzi, Alberto Giannoni, Roberta Poletti, Giovanni Iudice, Francesca Bramanti, Claudio Passino · 2017 · Journal of the American College of Cardiology
21. B-lines with Lung Ultrasound: The Optimal Scan Technique at Rest and During Stress
    Maria Chiara Scali, A Zagatina, Iana Ivaylova Simova, Nadezhda ZHURAVSKAYA, Quirino Ciampi, Marco Paterni, Mario Marzilli, Clara Carpeggiani, Eugenio Picano, Eugenio Picano et al. · 2017 · Ultrasound in Medicine & Biology
22. Physiological Dead Space and Arterial Carbon Dioxide Contributions to Exercise Ventilatory Inefficiency in Patients with Reduced or Preserved Ejection Fraction Heart Failure
    Erik H. Van Iterson, Bruce D. Johnson, Barry A. Borlaug, Thomas Patrick Olson · 2017 · European Journal of Heart Failure
23. Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure
    Jozine M. ter Maaten, Adriaan A. Voors, Kevin Damman, Peter van der Meer, Stefan D. Anker, John G.F. Cleland, Kenneth Dickstein, Gerasimos S Filippatos, Pim van der Harst, Hans L. Hillege et al. · 2018 · International Journal of Cardiology
24. Association of IL-8 With Infarct Size and Clinical Outcomes in Patients With STEMI
    Christian Shetelig, Shanmuganathan Limalanathan, Pavel Hoffmann, Ingebjørg Seljeflot, Jon Michael Gran, Jan Eritsland, Geir Øystein Andersen · 2018 · Journal of the American College of Cardiology
25. Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum
    Gianluigi Savarese, Åsa Jonsson, Ann-Charlotte Hallberg, Ulf Dahlström, Magnus Edner, Lars H. Lund · 2019 · International Journal of Cardiology
26. Potassium and the Use of Renin–Angiotensin–Aldosterone System Inhibitors in Heart Failure with Reduced Ejection Fraction: Data from BIOSTAT-CHF
    Joost C. Beusekamp, Jasper Tromp, Haye H. van der Wal, Stefan D. Anker, John G.F. Cleland, Kenneth Dickstein, Gerasimos S Filippatos, Pim van der Harst, Hans L. Hillege, Chim Choy Lang et al. · 2018 · European Journal of Heart Failure
27. Current Insights into Exercise-based Cardiac Rehabilitation in Patients with Coronary Heart Disease and Chronic Heart Failure
    Simon Nichols, G. McGregor, Jeff David Breckon, Lee Ingle · 2020 · International Journal of Sports Medicine
28. Optical nanomaterial-based detection of biomarkers in liquid biopsy
    Young Jun Kim, Won‐Yeop Rho, Seung-min Park, Bong‐Hyun Jun · 2024 · Journal of Hematology & Oncology
29. Effect of Digoxin in Patients with Heart Failure and Mid-Range (Borderline) Left Ventricular Ejection Fraction
    Azmil H. Abdul‐Rahim, Li Shen, Christopher J. Rush, Pardeep S. Jhund, Kennedy R. Lees, John J.V. McMurray · 2018 · European Journal of Heart Failure
30. Inotropes in Acute Heart Failure: From Guidelines to Practical Use: Therapeutic Options and Clinical Practice
    Vasiliki Bistola, Angelos Arfaras-Melainis, Effie Polyzogopoulou, Ignatios Ikonomidis, John Parissis · 2019 · Cardiac failure review
31. Potential Effects of Bariatric Surgery on the Incidence of Heart Failure and Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus and Obesity and on Mortality in Patients With Preexisting Heart Failure: A Nationwide, Matched, Observational Cohort Study
    Höskuldsdóttir, Gudrún, Sattar, Naveed, Miftaraj, Mervete, Näslund, Ingmar, Ottosson, Johan, Franzén, Stefan, Svensson, Ann‐Marie, Eliasson, Björn · 2021 · Journal of the American Heart Association
32. Prognostic impact of diabetes and prediabetes on survival outcomes in patients with chronic heart failure: a post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial
    Dauriz, Marco, Targher, Giovanni, Temporelli, Pier Luigi, Lucci, Donata, Gonzini, Lucio, Nicolosi, Gian Luigi, Marchioli, Roberto, Tognoni, Gianni, Latini, Roberto, Cosmi, Franco et al. · 2017 · Journal of the American Heart Association
33. What Proportion of Patients with Chronic Heart Failure are Eligible for Sacubitril–Valsartan?
    Pierpaolo Pellicori, Alessia Urbinati, Parin Purvin Shah, Alexandra Macnamara, Syed Kazmi, Riet Dierckx, Jufen Zhang, John G.F. Cleland, Andrew L. Clark · 2017 · European Journal of Heart Failure
34. Comparative Effects of an Angiotensin II Receptor Blocker (ARB)/Diuretic vs. ARB/Calcium-Channel Blocker Combination on Uncontrolled Nocturnal Hypertension Evaluated by Information and Communication Technology-Based Nocturnal Home Blood Pressure Monitoring ― The NOCTURNE Study ―
    Kazuomi Kario, Naoko Tomitani, Hiroshi Kanegae, Hajime Ishii, Kazuaki Uchiyama, Kayo Yamagiwa, Toshihiko Shiraiwa, Tomohiro Katsuya, Tetsuro Yoshida, Kiyomi Kanda et al. · 2017 · Circulation Journal
35. Metabolic Modulation of Cardiac Metabolism in Heart Failure
    Giuseppe M.C. Rosano, Cristiana Vitale · 2018 · Cardiac failure review
36. Imaging in Patients with Suspected Acute Heart Failure: Timeline Approach Position Statement on Behalf of the Heart Failure Association of the European Society of Cardiology
    Jelena Čelutkienė, Mitja Lainščak, Lisa Anderson, Étienne Gayat, Julia Grapsa, Veli‐Pekka Harjola, Robert Manka, Petros Nihoyannopoulos, Pasquale Perrone Filardi, Agathi Vrettou et al. · 2019 · European Journal of Heart Failure
37. A current and future outlook on upcoming technologies in remote monitoring of patients with heart failure
    Tarek Bekfani, Marat Fudim, John G.F. Cleland, Ana Jorbenadze, Stephan von Haehling, Avraham Lorber, Alexander M.K. Rothman, Kenneth M. Steín, William T. Abraham, Horst Sievert et al. · 2020 · European Journal of Heart Failure
38. [Retracted] Alleviation of Inflammation and Oxidative Stress in Pressure Overload‐Induced Cardiac Remodeling and Heart Failure via IL‐6/STAT3 Inhibition by Raloxifene
    Shengqi Huo, Wei Shi, Haiyan Ma, Dan Yan, Pengcheng Luo, Junyi Guo, Chenglong Li, Jiayuh Lin, Cuntai Zhang, Sheng Li et al. · 2021 · Oxidative Medicine and Cellular Longevity · Retracted
39. Prognostic impact of coronary microvascular dysfunction in patients with myocardial infarction with non-obstructive coronary arteries
    Fuad A. Abdu, Lu Liu, Abdul‐Quddus Mohammed, Guoqing Yin, Bin Xu, Wen Zhang, Siling Xu, Xian Lv, Rui Fan, Cailin Feng et al. · 2021 · European Journal of Internal Medicine
40. Telemedicine in Heart Failure: New Insights from the Cochrane Meta-Analyses
    Riet Dierckx, Sally C Inglis, Robyn A. Clark, David Prieto‐Merino, John G.F. Cleland · 2017 · European Journal of Heart Failure
41. Direct Comparison of Ultrafiltration to Pharmacological Decongestion in Heart Failure: A Per-Protocol Analysis of CARRESS-HF
    Justin Lee Grodin, Spencer J. Carter, Bradley A. Bart, Steven R. Goldsmith, Mark H. Drazner, W.H. Wilson Tang · 2018 · European Journal of Heart Failure
42. Long-Term Effect of Epirubicin on Incidence of Heart Failure in Women With Breast Cancer: Insight from a Randomized Clinical Trial
    Ann Banke, Emil Loldrup Fosbøl, Jacob Eifer Møller, Gunnar Gislason, Mads Jønsson Andersen, Mogens Bernsdorf, Maj‐Britt Jensen, Morten Schou, Bent Ejlertsen · 2018 · European Journal of Heart Failure
43. Arrhythmia-Induced Cardiomyopathy
    Samuel Tobias Sossalla, Dirk Vollmann · 2018 · Deutsches Ärzteblatt international
44. An AI-Based Heart Failure Treatment Adviser System
    Zhuo Chen, Elmer Salazar, Kyle Marple, Sandeep R. Das, Alpesh A. Amin, Daniel D. Cheeran, Lakshman S. Tamil, Gopal Gupta · 2018 · IEEE Journal of Translational Engineering in Health and Medicine
45. Transfusion-Associated Circulatory Overload: A Clinical Perspective
    Joachim J. Bosboom, Robert B. Klanderman, Yazan Migdady, Barbara Bolhuis, Denise Petra Veelo, Bart F. Geerts, Michael F. Murphy, Alexander P. J. Vlaar · 2019 · Transfusion Medicine Reviews
46. Heart failure, frailty, and pre-frailty: A systematic review and meta-analysis of observational studies
    Alessandra Marengoni, Alberto Zucchelli, Davide Liborio Vetrano, Gaetano Aloisi, Vincenzo Brandi, Marius Ciutan, Carmen Lavinia Panait, Roberto Bernabei, Graziano Onder, Katie Palmer · 2020 · International Journal of Cardiology
47. Left Ventricular Ejection Fraction and Heart Failure: An Indissoluble Marriage?
    Donato Mele, Marianna Nardozza, Roberto Ferrari · 2018 · European Journal of Heart Failure
48. Redefining Heart Failure With a Reduced Ejection Fraction
    Javed Butler, Stefan D. Anker, Milton Packer · 2019 · JAMA
49. Role of comorbidities in heart failure prognosis Part I: Anaemia, iron deficiency, diabetes, atrial fibrillation
    Stefania Paolillo, Angela Beatrice Scardovi, Jeness Campodonico · 2020 · European Journal of Preventive Cardiology
50. Dietary interventions and nutritional supplements for heart failure: a systematic appraisal and evidence map
    Muhammad Shahzeb Khan, Fiza Khan, Gregg C. Fonarow, Jayakumar Sreenivasan, Stephen John Greene, Safi Ullah Khan, Muhammad Usman, Muthiah Vaduganathan, Marat Fudim, Stefan D. Anker et al. · 2021 · European Journal of Heart Failure
51. Natriuresis‐guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium‐based treatment algoritHm in Acute Heart Failure ( PUSH‐AHF ) trial
    Jozine M. ter Maaten, Iris E. Beldhuis, Peter van der Meer, Jan A. Krikken, Jenifer E. Coster, Wybe Nieuwland, Dirk Jan van Veldhuisen, Adriaan A. Voors, Kevin Damman · 2021 · European Journal of Heart Failure
52. Guideline-Directed Medical Therapy for the Treatment of Heart Failure with Reduced Ejection Fraction
    Jay Patel, Negin Rassekh, Gregg C. Fonarow, PRAKASH C. DEEDWANIA, Farooq H. Sheikh, Ali Ahmed, Phillip Hong Lam · 2023 · Drugs
53. Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage
    Andrew J.S. Coats, S Jain · 2017 · Journal of Human Hypertension
54. Haemodynamic and Metabolic Phenotyping of Hypertensive Patients with and without Heart Failure by Combining Cardiopulmonary and Echocardiographic Stress Test
    Nicola Riccardo Pugliese, Matteo Mazzola, Iacopo Fabiani, Luna Gargani, Nicolò De Biase, Roberto Pedrinelli, Andrea Natali, Frank Lloyd Dini · 2020 · European Journal of Heart Failure
55. Association Between Loop Diuretic Dose Changes and Outcomes in Chronic Heart Failure: Observations from the ESC-EORP Heart Failure Long-Term Registry
    Chris J. Kapelios, Cécile Laroche, María G. Crespo‐Leiro, Stefan D. Anker, Andrew J.S. Coats, Beatriz Díaz Molina, Gerasimos S Filippatos, Mitja Lainščak, Aldo Pietro Maggioni, Theresa A. McDonagh et al. · 2020 · European Journal of Heart Failure
56. Novel endotypes in heart failure: effects on guideline-directed medical therapy
    Jasper Tromp, Wouter Ouwerkerk, Biniyam G. Demissei, Stefan D. Anker, John G.F. Cleland, Kenneth Dickstein, Gerasimos S Filippatos, Pim van der Harst, Hans L. Hillege, Chim Choy Lang et al. · 2018 · European Heart Journal
57. A randomised, double‐blind, placebo‐controlled trial of metformin on myocardial efficiency in insulin‐resistant chronic heart failure patients without diabetes
    A. H. Larsen, N. Jessen, H. Nørrelund, L. Tolbod, H. Harms, S. Feddersen, F. Nielsen, K. Brøsen, N. H. Hansson, J. Frøkiær et al. · 2019 · European Journal of Heart Failure
58. Effects of Spironolactone on Serum Markers of Fibrosis in People at High Risk of Developing Heart Failure: Rationale, Design and Baseline Characteristics of a Proof-of-Concept, Randomised, Precision-Medicine, Prevention Trial. The Heart OMics in AGing (HOMAGE) Trial
    Pierpaolo Pellicori, João Pedro Ferreira, Beatrice Mariottoni, Hans‐Peter Brunner‐La Rocca, Fozia Zahir Ahmed, Job A.J. Verdonschot, Timothy John Collier, Joseph James Cuthbert, Johannes Petutschnigg, Blerim Mujaj et al. · 2020 · European Journal of Heart Failure
59. Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system
    Milo Gatti, Ippazio Cosimo Antonazzo, Igor Diemberger, Fabrizio De Ponti, Emanuel Raschi · 2020 · European Journal of Preventive Cardiology
60. Combined aerobic/resistance/inspiratory muscle training as the ‘optimum’ exercise programme for patients with chronic heart failure: ARISTOS-HF randomized clinical trial
    Ioannis D. Laoutaris, Ewa Piotrowicz, Manolis S. Kallistratos, Athanasios Dritsas, Niki Dimaki, Dimitrios Miliopoulos, Maria Andriopoulou, Athanasios John Manolis, Maurizio Volterrani, Massimo Francesco Piepoli et al. · 2020 · European Journal of Preventive Cardiology
61. First in man evaluation of a novel circulatory support device: Early experience with the Impella 5.5 after CE mark approval in Germany
    Alexander M. J. Bernhardt, Evgenij V Potapov, David Schibilsky, Arjang Ruhparwar, Carsten Tschöpe, Frank Spillmann, Christoph Benk, Bastian Schmack, Jan Dieter Schmitto, Lars Christian Napp et al. · 2021 · The Journal of Heart and Lung Transplantation
62. Adding Defibrillation Therapy to Cardiac Resynchronization on the Basis of the Myocardial Substrate
    Sérgio Barra, Serge Bovéda, Rui Andre Providencia, Nicolas Sadoul, Rudolf Martin Duehmke, Christian Reitan, Rasmus Borgquist, Kumar Narayanan, Françoise Hidden‐Lucet, Didier Klug et al. · 2017 · Journal of the American College of Cardiology
63. Heart Failure with Preserved Ejection Fraction in Older Adults
    Bharathi Upadhya, Dalane W. Kitzman · 2017 · Heart Failure Clinics
64. Mechanism of Abnormal Septal Motion in Left Bundle Branch Block
    John Moene Aalen, Espen Wattenberg Remme, Camilla Kjellstad Larsen, Øyvind Senstad Andersen, Magnus Reinsfelt Krogh, Jürgen Duchenne, Einar Hopp, Stian Ross, Ahmed Salem Beela, Erik Kongsgaard et al. · 2019 · JACC. Cardiovascular imaging
65. The effectiveness of remote monitoring of elderly patients after hospitalisation for heart failure: The renewing health European project
    Zoran Olivari, Sara Giacomelli, Lorenzo Gubian, Silvia Mancin, Elisa Visentin, Vincenzo Di Francesco, Sabino Iliceto, Michelangelo Penzo, Albino Zanocco, Carlo Marcon et al. · 2018 · International Journal of Cardiology
66. Relationships between exercise capacity and anxiety, depression, and cognition in patients with heart failure
    Oronzo Chialà, Ercole Vellone, Leonie Verheijden Klompstra, Giorgio Alberto Ortali, Anna Strömberg, Tiny Jaarsma · 2018 · Heart & Lung
67. Initiation of Sacubitril/Valsartan Shortly After Hospitalisation for Acutely Decompensated Heart Failure in Patients with Newly Diagnosed ( de novo ) Heart Failure: A Subgroup Analysis of the TRANSITION Study
    Michele Senni, Rolf Wachter, Klaus Karl Witte, Ewa Straburzyńska‐Migaj, Jan Bělohlávek, Cândida Fonseca, Christian Eugen Mueller, Eva Lonn, Arhit Chakrabarti, Weibin Bao et al. · 2019 · European Journal of Heart Failure
68. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Acute Admissions at the Emergency and Cardiology Departments Across Europe
    Mateusz Sokolski, Piotr Gajewski, Robert Zymliński, Jan Biegus, Jurriën M. ten Berg, Willem L. Bor, Frieder Braunschweig, Daniel Caldeira, Florim Cuculi, Emilia D’Elia et al. · 2020 · The American Journal of Medicine
69. Feasibility of home-based cardiac rehabilitation using an integrated telerehabilitation platform in elderly patients with heart failure: A pilot study
    Atsushi Kikuchi, Tatsunori Taniguchi, Kei Nakamoto, Fusako Sera, Tomohito Ohtani, Takahisa Yamada, Yasushi Sakata · 2021 · Journal of Cardiology
70. Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT‐CHF
    Matteo Pagnesi, Marianna Adamo, Iziah Edwin Sama, Stefan D. Anker, John G.F. Cleland, Kenneth Dickstein, Gerasimos S Filippatos, Chim Choy Lang, Leong L. Ng, Piotr P. Ponikowski et al. · 2021 · European Journal of Heart Failure
71. Inflammatory Cytokines, Immune Cells, and Organ Interactions in Heart Failure
    Huihui Li, Chen Chen, Dao Wen Wang · 2021 · Frontiers in Physiology
72. Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the S wedish H eart F ailure R egistry
    Peter Moritz Becher, Benedikt Schrage, Lina Benson, Marat Fudim, Carin Corovic Cabrera, Ulf Dahlström, Giuseppe M.C. Rosano, Ewa Anita Jankowska, Stefan D. Anker, Lars H. Lund et al. · 2021 · European Journal of Heart Failure
73. Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
    Zoltán Papp, Piergiuseppe Agostoni, Julián Álvarez, Dominique Béttex, Stefan Bouchez, Dulce A. Brito, Vladimír Černý, Josep Comin Colet, Maria Generosa Crespo-Leiro, Juan F. Delgado et al. · 2020 · Cardiac failure review
74. Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases
    Danni Mu, Jin Hua Cheng, Ling Qiu, Xinqi Cheng · 2022 · Frontiers in Cardiovascular Medicine
75. Use of guideline‐recommended medical therapy in patients with heart failure and chronic kidney disease: from physician's prescriptions to patient's dispensations, medication adherence and persistence
    Roemer J. Janse, Edouard L. Fu, Ulf Dahlström, Lina Benson, Bengt Lindholm, Merel van Diepen, Friedo Wilhelm Dekker, Lars H. Lund, Juan Jesús Carrero, Gianluigi Savarese · 2022 · European Journal of Heart Failure
76. Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy
    Jan‐Thorben Sieweke, Tobias Jonathan Pfeffer, Dominik Berliner, Tobias König, Maximiliane Hallbaum, Lars Christian Napp, Jörn Tongers, C. Kühn, Jan Dieter Schmitto, Denise Hilfiker‐Kleiner et al. · 2018 · European Heart Journal Acute Cardiovascular Care
77. The association of long-term outcome and biological sex in patients with acute heart failure from different geographic regions
    Justina Motiejūnaitė, Eiichi Akiyama, Alain Cohen Solal, Aldo Pietro Maggioni, Christian Eugen Mueller, Dong‐Ju Choi, Aušra Kavoliūnienė, Jelena Čelutkienė, Jiří Pařenica, Johan P.E. Lassus et al. · 2020 · European Heart Journal
78. Polycystins, ADPKD, and Cardiovascular Disease
    Ivana Y. Kuo, Arlene B. Chapman · 2019 · Kidney International Reports
79. Multiple roles of cardiac macrophages in heart homeostasis and failure
    Aneta Moskalik, Justyna Niderla‐Bielińska, Anna Ratajska · 2021 · Heart Failure Reviews
80. The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
    Daniele Masarone, Maria Luigia Martucci, Vittoria Errigo, Giuseppe Pacileo · 2021 · Journal of Cardiovascular Development and Disease
81. Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy
    Farah Cadour, Morgane Quemeneur, Loïc Bière, Erwan Donal, Zakarya Bentatou, Jean‐Christophe Eicher, François Roubille, Alain Lalande, Roch Giorgi, Stanislas Rapacchi et al. · 2023 · Journal of Cardiovascular Magnetic Resonance
82. Improving care for heart failure patients in primary care, GPs' perceptions: a qualitative evidence synthesis
    Miek Smeets, Sara Van Roy, Bert Aertgeerts, Mieke Vermandere, Bert Vaes · 2016 · BMJ Open
83. Prevalence of Hyperuricemia in Patients With Acute Heart Failure With Either Reduced or Preserved Ejection Fraction
    Alberto Palazzuoli, Gaetano M. Ruocco, Oreste De Vivo, Ranuccio Nuti, Peter Andrew McCullough · 2017 · The American Journal of Cardiology
84. Prioritizing symptom management in the treatment of chronic heart failure
    Koshy, Aaron O., Gallivan, Elisha R., McGinlay, Melanie, Straw, Sam, Drozd, Michael, Toms, Anet G., Gierula, John, Cubbon, Richard M., Kearney, Mark T., Witte, Klaus K. · 2020 · ESC Heart Failure
85. Left Ventricular Geometry as a Major Determinant of Left Ventricular Ejection Fraction: Physiological Considerations and Clinical Implications
    Filippos K. Triposkiadis, Grigorios Giamouzis, Konstantinos Dean Boudoulas, Georgios Karagiannis, John S. Skoularigis, Harisios K Boudoulas, John Parissis · 2017 · European Journal of Heart Failure
86. Renal Function Stratified Dose Comparisons of Eplerenone Versus Placebo in the EMPHASIS-HF Trial
    João Pedro Ferreira, Paula C. Abreu, John J.V. McMurray, Dirk Jan van Veldhuisen, Karl B Swedberg, Stuart Pocock, John Vincent, Katharina Lins, Patrick Rossignol, Bertram Pitt et al. · 2019 · European Journal of Heart Failure
87. Consensus recommendations for management of patients with type 2 diabetes mellitus and cardiovascular diseases
    Alaaeldin M. Bashier, Azza Khalifa Bin Hussain, Elamin Abdelgadir, Fatheya Alawadi, Hani Mohamed Sabbour, ROBERT J. CHILTON · 2019 · Diabetology & Metabolic Syndrome
88. Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease
    Clarisse Roux‐Marson, Jean-Baptiste Baranski, Coraline Fafin, Guillaume Exterman, Cecile M. Vigneau, Cécile Couchoud, Olivier P. Moranne, P. S. P. A. Investigators · 2020 · BMC Geriatrics
89. The combination of carboxy‐terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy – A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy
    Anne G. Raafs, Job A.J. Verdonschot, Michiel T.H.M. Henkens, Bouke P. Adriaans, Ping Wang, Kasper Derks, Myrurgia A. Abdul Hamid, Christian Knackstedt, Vanessa P. M. van Empel, Javier Dı́ez et al. · 2021 · European Journal of Heart Failure
90. Ring-like late gadolinium enhancement for predicting ventricular tachyarrhythmias in non-ischaemic dilated cardiomyopathy
    Wensu Chen, Wen Qian, Xinwei Zhang, Dongcheng Li, Zhiyong Qian, Hai Xu, Shengen Liao, Xing Chen, Yao Wang, Xiaofeng Hou et al. · 2021 · European Heart Journal - Cardiovascular Imaging
91. Heart failure survival prediction using machine learning algorithm: am I safe from heart failure?
    Muntasir Mamun, Afia Farjana, Miraz Al Mamun, Md Salim Ahammed, Md Minhazur Rahman · 2022 · IEEE World AI IoT Congress (AIIoT)
92. Anxiety and self-care behaviour in patients with chronic systolic heart failure: a multivariate model
    Müller-Tasch, Thomas, Löwe, Bernd, Lossnitzer, Nicole, Frankenstein, Lutz, Täger, Tobias, Haass, Markus, Katus, Hugo, Schultz, Jobst-Hendrik, Herzog, Wolfgang · 2018 · European Journal of Cardiovascular Nursing
93. A Network Analysis to Compare Biomarker Profiles in Patients with and without Diabetes Mellitus in Acute Heart Failure
    Abhinav Sharma, Biniyam G. Demissei, Jasper Tromp, Hans L. Hillege, John G.F. Cleland, Christopher M. O’Connor, Marco Metra, Piotr P. Ponikowski, John R. Teerlink, Beth A. Davison et al. · 2017 · European Journal of Heart Failure
94. Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP and GDF-15, of Heart Failure Therapies (STRONG-HF): Rationale and Design for a Multicentre, Randomized, Parallel-Group Study
    Antoine Kimmoun, Gad Cotter, Beth A. Davison, Koji Takagi, Faouzi Addad, Jelena Čelutkienė, Ovidiu Chioncel, Alain Cohen Solal, Rafael Díaz, Albertino Antonio Moura Damasceno et al. · 2019 · European Journal of Heart Failure
95. Correlation of left atrial strain with left ventricular end-diastolic pressure in patients with normal left ventricular ejection fraction
    Jiali Fan, Bo Yang Su, Xin Zhao, Bingyuan Zhou, Changsheng Ma, Haipeng Wang, Shengda Hu, Yafeng Zhou, Yi-Jiao Ju, Minghan Wang · 2020 · International journal of cardiac imaging
96. Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism?
    Nils Bömer, Mario Pávez, Niels Grote Beverborg, John G.F. Cleland, Dirk Jan van Veldhuisen, Peter van der Meer · 2022 · Journal of Internal Medicine
97. Effects of Sildenafil on Cardiac Structure and Function, Cardiopulmonary Exercise Testing and Health-Related Quality of Life Measures in Heart Failure Patients with Preserved Ejection Fraction and Pulmonary Hypertension
    Licette C.Y. Liu, Yoran M. Hummel, Peter van der Meer, Rolf M.F. Berger, Kevin Damman, Dirk Jan van Veldhuisen, Adriaan A. Voors, Elke S. Hoendermis · 2016 · European Journal of Heart Failure
98. Risk of Heart Failure in Obese Patients With and Without Bariatric Surgery in Sweden—A Registry-Based Study
    Christina E Persson, Lena M Bjorck, Jesper Lagergren, Georgios Lappas, Kok Wai Giang, Annika Rosengren · 2017 · Journal of Cardiac Failure
99. Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology
    Camilla Normand, David M. Kaye, Thomas Joseph Povsic, Kenneth Dickstein · 2019 · The Lancet
100. Real-World Treatment Patterns of Sacubitril/Valsartan: A Longitudinal Cohort Study in Germany
     Rolf Wachter, Ana Filipa Fonseca, Bogdan Balas, Elisabeth J. Kap, J. Engelhard, Raymond G. Schlienger, Sven H. G. Klebs, Sara Bruce Wirta, Karel Kostev · 2019 · European Journal of Heart Failure